Mice expressing soluble TβRII under the regulation of the MMTV/LTR promoter exhibit high levels of the TGF-β antagonist in the circulation which suppress metastases from Neu-induced mammary tumors as well as metastases resulting from injected B16 melanoma cells [51]. This evidence concerns the gene TGFB1 and breast cancer.